Tofflon Science and Technology Group Co., Ltd. (300171.SZ)
CNY 14.33
(-0.14%)
CNY 14.33
(-0.14%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 6.6 Million CNY | 18.19% |
| 2022 | 5.58 Million CNY | -32.15% |
| 2021 | 8.23 Million CNY | 165.15% |
| 2020 | 3.1 Million CNY | 5.78% |
| 2019 | 2.93 Million CNY | -76.14% |
| 2018 | 12.29 Million CNY | -81.26% |
| 2017 | 65.62 Million CNY | 1212.44% |
| 2016 | 5 Million CNY | -50.0% |
| 2015 | 10 Million CNY | 0.0% |
| 2014 | 10 Million CNY | 233.33% |
| 2013 | 3 Million CNY | -83.33% |
| 2012 | 18 Million CNY | 0.0% |
| 2011 | - CNY | -100.0% |
| 2010 | 16 Million CNY | 0.0% |
| 2009 | - CNY | -100.0% |
| 2008 | 10 Million CNY | 0.0% |
| 2007 | - CNY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q3 | 3 Million CNY | 45.18% |
| 2024 Q1 | 5.12 Million CNY | -22.3% |
| 2024 Q2 | 3.65 Million CNY | -28.82% |
| 2023 Q4 | 6.6 Million CNY | 53.61% |
| 2023 Q3 | 4.29 Million CNY | -11.34% |
| 2023 Q2 | 4.84 Million CNY | 13.7% |
| 2023 Q1 | 4.26 Million CNY | -23.67% |
| 2023 FY | 6.6 Million CNY | 18.19% |
| 2022 Q3 | 4.4 Million CNY | -33.09% |
| 2022 Q2 | 6.58 Million CNY | -10.13% |
| 2022 FY | 5.58 Million CNY | -32.15% |
| 2022 Q4 | 5.58 Million CNY | 26.79% |
| 2022 Q1 | 7.32 Million CNY | -11.0% |
| 2021 Q1 | - CNY | -100.0% |
| 2021 FY | 8.23 Million CNY | 165.15% |
| 2021 Q4 | 8.23 Million CNY | 0.0% |
| 2021 Q2 | 1.5 Million CNY | 0.0% |
| 2021 Q3 | - CNY | -100.0% |
| 2020 Q3 | - CNY | -100.0% |
| 2020 Q4 | 3.07 Million CNY | 0.0% |
| 2020 Q1 | - CNY | -100.0% |
| 2020 Q2 | 896.2 Thousand CNY | 0.0% |
| 2020 FY | 3.1 Million CNY | 5.78% |
| 2019 Q3 | - CNY | -100.0% |
| 2019 Q1 | - CNY | -100.0% |
| 2019 FY | 2.93 Million CNY | -76.14% |
| 2019 Q4 | 464.62 Thousand CNY | 0.0% |
| 2019 Q2 | 423.21 Thousand CNY | 0.0% |
| 2018 Q2 | 2.87 Million CNY | 0.0% |
| 2018 Q3 | - CNY | -100.0% |
| 2018 Q1 | - CNY | -100.0% |
| 2018 FY | 12.29 Million CNY | -81.26% |
| 2018 Q4 | 3.08 Million CNY | 0.0% |
| 2017 Q4 | 4.09 Million CNY | 0.0% |
| 2017 Q3 | - CNY | -100.0% |
| 2017 Q2 | 5 Million CNY | -48.2% |
| 2017 Q1 | 9.65 Million CNY | 93.04% |
| 2017 FY | 65.62 Million CNY | 1212.44% |
| 2016 FY | 5 Million CNY | -50.0% |
| 2016 Q1 | 10 Million CNY | 0.0% |
| 2016 Q2 | 10 Million CNY | 0.0% |
| 2016 Q4 | 5 Million CNY | -50.0% |
| 2016 Q3 | 10 Million CNY | 0.0% |
| 2015 Q4 | 10 Million CNY | 0.0% |
| 2015 FY | 10 Million CNY | 0.0% |
| 2015 Q3 | 10 Million CNY | 0.0% |
| 2015 Q2 | 10 Million CNY | 0.0% |
| 2015 Q1 | 10 Million CNY | 0.0% |
| 2014 Q4 | 10 Million CNY | 0.0% |
| 2014 FY | 10 Million CNY | 233.33% |
| 2014 Q3 | 10 Million CNY | 212.24% |
| 2014 Q2 | 3.2 Million CNY | 0.0% |
| 2014 Q1 | - CNY | -100.0% |
| 2013 Q3 | - CNY | -100.0% |
| 2013 Q4 | 3 Million CNY | 0.0% |
| 2013 FY | 3 Million CNY | -83.33% |
| 2013 Q1 | 18 Million CNY | 0.0% |
| 2013 Q2 | 3 Million CNY | -83.33% |
| 2012 Q1 | - CNY | 0.0% |
| 2012 Q2 | 18 Million CNY | 0.0% |
| 2012 Q4 | 18 Million CNY | 0.0% |
| 2012 FY | 18 Million CNY | 0.0% |
| 2012 Q3 | 18 Million CNY | 0.0% |
| 2011 Q2 | 16 Million CNY | 0.0% |
| 2011 Q1 | 16 Million CNY | 0.0% |
| 2011 FY | - CNY | -100.0% |
| 2011 Q3 | 16 Million CNY | 0.0% |
| 2011 Q4 | - CNY | -100.0% |
| 2010 Q3 | - CNY | 0.0% |
| 2010 Q4 | 16 Million CNY | 0.0% |
| 2010 Q2 | - CNY | 0.0% |
| 2010 FY | 16 Million CNY | 0.0% |
| 2009 FY | - CNY | -100.0% |
| 2009 Q4 | - CNY | 0.0% |
| 2008 FY | 10 Million CNY | 0.0% |
| 2007 FY | - CNY | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. | 1.61 Billion CNY | 99.591% |
| Shenzhen Salubris Pharmaceuticals Co., Ltd. | 63.46 Million CNY | 89.599% |
| Blue Sail Medical Co.,Ltd. | 3.85 Billion CNY | 99.829% |
| Andon Health Co., Ltd. | 1.57 Billion CNY | 99.582% |
| Allmed Medical Products Co., Ltd | 970.19 Million CNY | 99.32% |
| Improve Medical Instruments Co., Ltd. | 400.42 Million CNY | 98.352% |
| Truking Technology Limited | 1.32 Billion CNY | 99.502% |
| Jiangxi Sanxin Medtec Co.,Ltd. | 342.85 Million CNY | 98.075% |
| Shenyang Xingqi Pharmaceutical Co.,Ltd | 91.09 Million CNY | 92.754% |
| Autek China Inc. | 344.76 Million CNY | 98.085% |
| Intco Medical Technology Co., Ltd. | 7.16 Billion CNY | 99.908% |
| Jiangsu Apon Medical Technology Co., Ltd. | 76.41 Million CNY | 91.362% |
| Winner Medical Co., Ltd. | 2.49 Billion CNY | 99.735% |
| Imeik Technology Development Co.,Ltd. | 52.46 Million CNY | 87.418% |
| Zhonghong Pulin Medical Products Co., Ltd. | 662.53 Million CNY | 99.004% |
| Caina Technology Co., Ltd. | 429.46 Thousand CNY | -1436.984% |